Medicago's vaccine greenhouse (Medicago via YouTube)

Cana­di­an plant-based vac­cine de­vel­op­er Med­ica­go shut­ters months af­ter lay­offs

Plant-based Covid-19 vac­cine de­vel­op­er Med­ica­go shut down this week with lit­tle fan­fare. And its two sub­sidiaries, Med­ica­go R&D and Med­ica­go USA, are al­so clos­ing their doors, ac­cord­ing to a com­pa­ny news re­lease.

The lone share­hold­er left stand­ing, Japan-based Mit­subishi Chem­i­cal Group, “has de­ter­mined not to make fur­ther in­vest­ments in Med­ica­go and to pro­ceed with an or­der­ly wind-up of its busi­ness and op­er­a­tions in Cana­da and in the Unit­ed States.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.